Hot Flashes Market Outlook, Trends And Future Opportunities (2024-2031)

Hot Flashes Market Outlook, Trends And Future Opportunities (2024-2031)

Hot Flashes Market, By Treatment Type (Hormone Therapy, Non-hormonal Therapy, Alternative Therapies, Others), By Product Type (Oral, Transdermal, Vaginal, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others), By End User (Hospitals, Gynecology Clinics, Ambulatory Surgical Centers, Others), By Severity (Mild Hot Flashes, Moderate Hot Flashes, Severe Hot Flashes), By Causative Factor (Natural Menopause, Surgical Menopause, Chemotherapy-induced Menopause, Others), Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) The report offers a comprehensive view of the market from supply as well as demand side to help take informed decisions.

  • Published On: Jun 2024
  • Author(s): Sagar Karlekar
  • Report ID: IDA162
  • Region: Global
  • Format: PDF/EXCEL

Table of Contents:

Chapter 1. Research Methodology and Scope

  • Market Segmentation and Scope
  • Regional Coverage
  • Objectives
  • Research Methodology

Chapter 2. Executive Summary

  • Market Landscape
  • Market Size & Forecast
  • Competitive Landscape

Chapter 3. Hot Flashes Market: By Treatment Type Segment Trends, Size, and Future Outlook

  • By Treatment Type Segment Market Size (US$), CAGR (%), and Forecast (2021-2031)
  • By Treatment Type Segment Definitions, Technology Landscape
  • By Treatment Type Segment Market Drivers
    • Product Launches
    • Technology Launches
    • Other Market Drivers Based on Previous Information
  • By Treatment Type Segment Market Restraints

Chapter 4. Hot Flashes Market: By Product Type Segment Trends, Size, and Future Outlook

  • By Product Type Segment Market Size (US$), CAGR (%), and Forecast (2021-2031)
  • By Product Type Segment Definitions, Technology Landscape
  • By Product Type Segment Market Drivers
    • Product Launches
    • Technology Launches
    • Other Market Drivers Based on Previous Information
  • By Product Type Segment Market Restraints

Chapter 5. Hot Flashes Market: By Distribution Channel Segment Trends, Size, and Future Outlook

  • By Distribution Channel Segment Market Size (US$), CAGR (%), and Forecast (2021-2031)
  • By Distribution Channel Segment Definitions, Technology Landscape
  • By Distribution Channel Segment Market Drivers
    • Product Launches
    • Technology Launches
    • Other Market Drivers Based on Previous Information
  • By Distribution Channel Segment Market Restraints

Chapter 6. Hot Flashes Market: By End User Segment Trends, Size, and Future Outlook

  • By End User Segment Market Size (US$), CAGR (%), and Forecast (2021-2031)
  • By End User Segment Definitions, Technology Landscape
  • By End User Segment Market Drivers
    • Product Launches
    • Technology Launches
    • Other Market Drivers Based on Previous Information
  • By End User Segment Market Restraints

Chapter 7. Hot Flashes Market: By Severity Segment Trends, Size, and Future Outlook

  • By Severity Segment Market Size (US$), CAGR (%), and Forecast (2021-2031)
  • By Severity Segment Definitions, Technology Landscape
  • By Severity Segment Market Drivers
    • Product Launches
    • Technology Launches
    • Other Market Drivers Based on Previous Information
  • By Severity Segment Market Restraints

Chapter 8. Hot Flashes Market: By Causative Factor Segment Trends, Size, and Future Outlook

  • By Causative Factor Segment Market Size (US$), CAGR (%), and Forecast (2021-2031)
  • By Causative Factor Segment Definitions, Technology Landscape
  • By Causative Factor Segment Market Drivers
    • Product Launches
    • Technology Launches
    • Other Market Drivers Based on Previous Information
  • By Causative Factor Segment Market Restraints

Chapter 9. Hot Flashes Market: Regional Market Trends, Size, and Future Outlook

  • North America
    • Market Size (US$), CAGR (%), and Forecast (2021-2031)
    • Definitions, Technology Landscape
    • Market Drivers
      • Product Launches
      • Technology Launches
      • Other Market Drivers Based on Previous Information
    • Market Restraints
    • Competitive Outlook
  • Europe
    • Market Size (US$), CAGR (%), and Forecast (2021-2031)
    • Definitions, Technology Landscape
    • Market Drivers
      • Product Launches
      • Technology Launches
      • Other Market Drivers Based on Previous Information
    • Market Restraints
    • Competitive Outlook
  • Asia Pacific
    • Market Size (US$), CAGR (%), and Forecast (2021-2031)
    • Definitions, Technology Landscape
    • Market Drivers
      • Product Launches
      • Technology Launches
      • Other Market Drivers Based on Previous Information
    • Market Restraints
    • Competitive Outlook
  • Latin America
    • Market Size (US$), CAGR (%), and Forecast (2021-2031)
    • Definitions, Technology Landscape
    • Market Drivers
      • Product Launches
      • Technology Launches
      • Other Market Drivers Based on Previous Information
    • Market Restraints
    • Competitive Outlook
  • Middle East, and Africa
    • Market Size (US$), CAGR (%), and Forecast (2021-2031)
    • Definitions, Technology Landscape
    • Market Drivers
      • Product Launches
      • Technology Launches
      • Other Market Drivers Based on Previous Information
    • Market Restraints
    • Competitive Outlook

Chapter 10. Hot Flashes Market: Competitive Landscape

  • Pfizer Inc.
    • Company Overview
    • Financial Outlook
    • Product Portfolio
    • Strategies
  • Novartis AG
    • Company Overview
    • Financial Outlook
    • Product Portfolio
    • Strategies
  • Eli Lilly and Company
    • Company Overview
    • Financial Outlook
    • Product Portfolio
    • Strategies
  • Hisamitsu Pharmaceutical Co., Inc.
    • Company Overview
    • Financial Outlook
    • Product Portfolio
    • Strategies
  • Merck & Co., Inc.
    • Company Overview
    • Financial Outlook
    • Product Portfolio
    • Strategies
  • Novo Nordisk A/S
    • Company Overview
    • Financial Outlook
    • Product Portfolio
    • Strategies
  • Bayer AG
    • Company Overview
    • Financial Outlook
    • Product Portfolio
    • Strategies
  • Amgen Inc.
    • Company Overview
    • Financial Outlook
    • Product Portfolio
    • Strategies
  • Mylan N.V.
    • Company Overview
    • Financial Outlook
    • Product Portfolio
    • Strategies
  • TherapeuticsMD, Inc.
    • Company Overview
    • Financial Outlook
    • Product Portfolio
    • Strategies
  • Kyowa Kirin Co., Ltd.
    • Company Overview
    • Financial Outlook
    • Product Portfolio
    • Strategies
  • Allergan plc
    • Company Overview
    • Financial Outlook
    • Product Portfolio
    • Strategies
  • Noven Pharmaceuticals, Inc.
    • Company Overview
    • Financial Outlook
    • Product Portfolio
    • Strategies
  • Endoceutics, Inc.
    • Company Overview
    • Financial Outlook
    • Product Portfolio
    • Strategies
  • Astellas Pharma Inc.
    • Company Overview
    • Financial Outlook
    • Product Portfolio
    • Strategies
  • Ogeda SA
    • Company Overview
    • Financial Outlook
    • Product Portfolio
    • Strategies
  • Catalent, Inc.
    • Company Overview
    • Financial Outlook
    • Product Portfolio
    • Strategies
  • Piramal Enterprises Ltd.
    • Company Overview
    • Financial Outlook
    • Product Portfolio
    • Strategies
  • Hologic, Inc.
    • Company Overview
    • Financial Outlook
    • Product Portfolio
    • Strategies
  • Biodelivery Sciences International, Inc.
    • Company Overview
    • Financial Outlook
    • Product Portfolio
    • Strategies

Research Methodology

  • Primary Research
  • Secondary Research
  • Assumptions
  • IDataAcumen Analysis
  • Paid Databases

Appendix

  • About Us

Frequently Asked Questions

The current market size of the Hot Flashes industry is USD 2.1 billion.

Increasing aging population, rising awareness about menopause, favorable reimbursement policies, expanding therapeutic options, shift towards non-hormonal treatments, adoption of wearable devices, personalized treatment approaches, and growth of alternative therapies.

Side effects of treatments, lack of awareness, high treatment costs, stigma associated with menopause, regulatory hurdles, limited access to healthcare in some regions, and patent expiries of branded drugs.

The hormone therapy segment is the leading component segment in the Hot Flashes Market due to widespread use of estrogen-based therapies.

Pfizer Inc., Novartis AG, Eli Lilly and Company, Hisamitsu Pharmaceutical Co., Inc., Merck & Co., Inc., Novo Nordisk A/S, Bayer AG, Amgen Inc., Mylan N.V., TherapeuticsMD, Inc., Kyowa Kirin Co., Ltd., Allergan plc, Noven Pharmaceuticals, Inc., Endoceutics, Inc., Astellas Pharma Inc., Ogeda SA, Catalent, Inc., Piramal Enterprises Ltd., Hologic, Inc., and Biodelivery Sciences International, Inc.

North America is expected to lead the Hot Flashes Market, with a CAGR of around 8-10% and a market size of USD 1.5 billion in 2024.

Increasing aging female population, rising awareness about menopause, favorable reimbursement policies, expanding therapeutic options, shift towards non-hormonal treatments, adoption of wearable devices, personalized treatment approaches, and growth of alternative therapies.